Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alteplase for acute ischemic stroke
NCT00412867Phase 4Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Dec 2006
- Primary completion
- Jun 2008
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of tissue-plasminogen activator in ischemic stroke, sponsored by Mitsubishi Tanabe Pharma. Started Dec 2006; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00412867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00412867.